A detailed history of Pnc Financial Services Group, Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,440 shares of MYGN stock, worth $207,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,440
Previous 5,266 79.26%
Holding current value
$207,302
Previous $112,000 105.36%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$17.98 - $25.47 $75,048 - $106,311
4,174 Added 79.26%
9,440 $230,000
Q1 2024

May 10, 2024

SELL
$17.59 - $23.59 $6,033 - $8,091
-343 Reduced 6.12%
5,266 $112,000
Q4 2023

Feb 09, 2024

SELL
$13.91 - $21.32 $10,529 - $16,139
-757 Reduced 11.89%
5,609 $107,000
Q3 2023

Nov 13, 2023

SELL
$15.99 - $23.22 $4,381 - $6,362
-274 Reduced 4.13%
6,366 $102,000
Q2 2023

Aug 11, 2023

SELL
$17.56 - $23.76 $4,688 - $6,343
-267 Reduced 3.87%
6,640 $153,000
Q1 2023

May 15, 2023

BUY
$15.26 - $23.75 $16,999 - $26,457
1,114 Added 19.23%
6,907 $160,000
Q4 2022

Feb 10, 2023

BUY
$14.51 - $20.99 $3,714 - $5,373
256 Added 4.62%
5,793 $84,000
Q3 2022

Nov 10, 2022

SELL
$18.21 - $27.88 $1,329 - $2,035
-73 Reduced 1.3%
5,537 $105,000
Q2 2022

Aug 12, 2022

BUY
$16.45 - $25.88 $2,418 - $3,804
147 Added 2.69%
5,610 $101,000
Q1 2022

May 12, 2022

SELL
$22.67 - $28.01 $14,440 - $17,842
-637 Reduced 10.44%
5,463 $137,000
Q4 2021

Feb 11, 2022

BUY
$24.13 - $32.63 $27,821 - $37,622
1,153 Added 23.31%
6,100 $168,000
Q3 2021

Nov 05, 2021

SELL
$29.97 - $36.66 $12,917 - $15,800
-431 Reduced 8.01%
4,947 $159,000
Q2 2021

Aug 06, 2021

BUY
$25.39 - $32.61 $1,701 - $2,184
67 Added 1.26%
5,378 $164,000
Q1 2021

May 07, 2021

BUY
$19.92 - $31.6 $12,728 - $20,192
639 Added 13.68%
5,311 $161,000
Q4 2020

Feb 12, 2021

BUY
$12.16 - $19.77 $1,896 - $3,084
156 Added 3.45%
4,672 $92,000
Q3 2020

Nov 06, 2020

BUY
$11.25 - $14.75 $22,117 - $28,998
1,966 Added 77.1%
4,516 $58,000
Q2 2020

Aug 07, 2020

SELL
$10.69 - $16.49 $28,403 - $43,813
-2,657 Reduced 51.03%
2,550 $28,000
Q1 2020

May 08, 2020

BUY
$9.78 - $29.53 $5,936 - $17,924
607 Added 13.2%
5,207 $74,000
Q4 2019

Feb 07, 2020

BUY
$20.93 - $35.1 $5,609 - $9,406
268 Added 6.19%
4,600 $125,000
Q3 2019

Nov 08, 2019

BUY
$22.08 - $47.08 $25,921 - $55,271
1,174 Added 37.18%
4,332 $124,000
Q2 2019

Aug 09, 2019

SELL
$22.67 - $35.0 $17,954 - $27,720
-792 Reduced 20.05%
3,158 $0
Q1 2019

May 10, 2019

BUY
$26.93 - $34.7 $2,127 - $2,741
79 Added 2.04%
3,950 $0
Q4 2018

Feb 08, 2019

SELL
$27.23 - $45.56 $14,023 - $23,463
-515 Reduced 11.74%
3,871 $112,000
Q3 2018

Nov 09, 2018

BUY
$37.57 - $50.34 $28,853 - $38,661
768 Added 21.23%
4,386 $0
Q2 2018

Aug 10, 2018

BUY
$27.75 - $40.17 $6,021 - $8,716
217 Added 6.38%
3,618 $0
Q1 2018

May 11, 2018

SELL
$28.83 - $41.01 $5,131 - $7,299
-178 Reduced 4.97%
3,401 $0
Q4 2017

Feb 09, 2018

BUY
$28.45 - $37.14 $10,298 - $13,444
362 Added 11.25%
3,579 $0
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $77,240 - $116,455
3,217
3,217 $0

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.